The Case of the Serial Sperm Donor
One man, hundreds of children and a burning question: Why?
Credit.Keith Negley
In 2015, Vanessa van Ewijk, a carpenter in the Netherlands, decided that she wanted to have a child. She was 34 and single, and so, like many women, she sought out a sperm donor.
She considered conceiving through a fertility clinic, but the cost was prohibitive for her. Instead, she found an ideal candidate through a website called Desire for a Child, one of a growing number of online sperm markets that match candidate donors directly with potential recipients. Ms. van Ewijk was drawn to one profile in particular, that of Jonathan Jacob Meijer, a Dutch musician in his 30s.
Published: Jan 26, 2021
84.8% and 73.3% of women reported clinically meaningful reductions in dysmenorrhea (menstrual pain) and non-menstrual pelvic pain at one year
82.8% average reduction from baseline
on the Numerical Rating Scale for dysmenorrhea from 7.4 (severe pain) to 1.3 (mild pain)
over one year
Bone mineral density loss was minimal at Week 24 and remained stable through one year
Data to be included in New Drug Application submission to U.S. Food and Drug Administration anticipated in first half of 2021
BASEL, Switzerland and NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) Myovant Sciences (NYSE: MYOV) and Pfizer Inc.. (NYSE: PFE) today announced that the Phase 3 SPIRIT long-term extension study of the investigational once-daily relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5 mg) in women with endometriosis reported clinically meaningful reductions in dysmenorrhea (menstrual pain) and non-menstrual pelvic pain ove
CLEVELAND, Ohio Readers have medical questions about COVID-19 and the coronavirus vaccine, and we’re getting answers from health care experts. Q: I would like an expert to address the concern that a lot of women have regarding the possibility of infertility as a result of getting the vaccine. I’ve heard of many women, specifically in health care, refusing the vaccine because of this concern. .
30 Jan 2021 - 9:42
WCM-Q alumnus Dr. Nigel Pereira.
The Peninsula
Doha: WCM-Q alumnus Dr. Nigel Pereira has been awarded a prestigious scholarship title in recognition of his excellence in research into the health of children conceived by in vitro fertilization (IVF).
Dr. Pereira, who graduated from Weill Cornell Medicine-Qatar (WCM-Q) in 2010, was named the ‘Tessler Grandchildren Clinical Scholar II’ by the Board of Overseers at Weill Cornell Medicine in New York, where he now practices as an Assistant Professor of Obstetrics and Gynecology and Assistant Professor of Reproductive Medicine.
The scholarship appointment recognizes Dr. Pereira’s excellence in research into both the immediate perinatal and long-term health of children conceived by IVF.
•84.8% and 73.3% of women reported clinically meaningful reductions in dysmenorrhea (menstrual pain) and non-menstrual pelvic pain at one year •Data to be included in New Drug Application submission to U.S. Food and Drug Administration anticipated in first half of 2021